Last updated on September 2018

A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma


Brief description of study

The primary objective of this study is to evaluate the tolerability and safety of a combination of lenvatinib plus nivolumab in participants with hepatocellular carcinoma (HCC).

Clinical Study Identifier: NCT03418922

Contact Investigators or Research Sites near you

Start Over

Customer Joy Department. EJ

Eisai Trial Site 4
Osakasayama, Japan
  Connect »